Ticlopidine Hydrochloride (Carilion Materials Management)
Welcome to the PulseAid listing for the Ticlopidine Hydrochloride drug offered from Carilion Materials Management. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | Ticlopidine Hydrochloride |
SUBSTANCE NAME: | TICLOPIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1999-09-07 |
END MARKETING DATE: | 0000-00-00 |
Ticlopidine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Ticlopidine Hydrochloride from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1999-09-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-0079_c01a9760-cfb9-4d0d-9cf6-12d9deff463f |
PRODUCT NDC: | 68151-0079 |
APPLICATION NUMBER: | ANDA075149 |
Other TICLOPIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: